Adriaan Volkers

5PUBLICATIONS
7CO-AUTHORS
Optical technologyPharmacogenomicsApplied immunology (incl. antibody engineering, xenotransplantation and t-cell therapies)Carbon sequestration science
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (5)

|Oct 14, 2024
Cost-effectiveness and cost-utility of optimized mercaptopurine treatment versus placebo in ulcerative colitis patients: The randomized controlled OPTIC trial.

Mark Löwenberg, Marit van Barreveld, Adriaan Volkers

|Feb 27, 2023
Mercaptopurine for the Treatment of Ulcerative Colitis: A Randomized Placebo-Controlled Trial.

Mark Löwenberg, Adriaan Volkers, Sara van Gennep

|Feb 23, 2023
Letter: tricky reactions to switch back from subcutaneous to intravenous vedolizumab in inflammatory bowel disease patients-authors' reply.

Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein

|Jul 23, 2022
Real-world experience of switching from intravenous to subcutaneous vedolizumab maintenance treatment for inflammatory bowel diseases.

Adriaan Volkers, Tessa Straatmijer, Marjolijn Duijvestein

|Dec 30, 2021
Assessment of endoscopic response using pan-enteric capsule endoscopy in Crohn's disease; the Sensitivity to Change (STOC) study.

Adriaan Volkers, Peter Bossuyt, Jitteke de Jong

Pageof 1